Status:
UNKNOWN
Nasal High Flow in Bariatric Surgery
Lead Sponsor:
Istanbul University
Conditions:
Morbid Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
High frequency nasal cannula (HFNC) provides an inspiration O2 fraction of 21-1% and it has a minimal dead space and can be well tolerated due to humidified air. Group I patients will be applied HFNC ...
Detailed Description
Morbid obese patients are prone to atelectasis and hypoxemia after bariatric surgery. High frequency nasal cannula (HFNC) provides an inspiration O2 fraction of 21-1% and it has a minimal dead space a...
Eligibility Criteria
Inclusion
- Patients with a body mass index of 40-55 kg/m2
- American Society of Anesthesiologists score II-III
- Patients undergoing laparoscopic sleeve gastrectomy or one anastomosis gastric bypass
Exclusion
- Obstructive sleep apnea syndrome
- Using a non invasive mechanical ventilation device preoperatively
- Patients whoo will predicted to postanesthesia care unit admission postoperatively
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04048798
Start Date
January 1 2020
End Date
February 1 2021
Last Update
August 7 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.